Market Tracker

09/28 5:48pm ET

BioDelivery Sciences International Inc (NASDAQ:BDSI)

2.94
Delayed Data
As of Sep 28
 +0.11 / +3.89%
Today’s Change
1.86
Today|||52-Week Range
7.04
-38.62%
Year-to-Date
Watch These 5 Huge Call Purchases In Wednesday Trade
Sep 28 / Benzinga - Paid Partner Content
BioDelivery Bunavail Gets Better Managed Care Positioning
Sep 20 / Zacks.com - Paid Partner Content
BioDelivery Sciences (BDSI) Stock Jumps on Ratings Upgrade
Sep 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close2.83
Today’s open2.86
Day’s range2.85 - 3.00
Volume1,218,592
Average volume (3 months)862,121
Market cap$151.8M
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+35.71%
Earnings growth (this year)-58.16%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+23.85%
P/E ratioNM
Price/Sales5.20
Price/Book4.71

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...-0.07-2.10%
NBRVNabriva Therapeutics...-0.10-1.36%
TTPHTetraphase Pharmaceu...-0.08-2.02%
FBIOFortress Biotech Inc-0.04-1.34%
Data as of 3:59pm ET, 09/28/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$48.2M
Annual profit (last year)-$37.7M
Net profit margin-78.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark A. Sirgo
Chief Financial Officer, Secretary &
Treasurer
Ernest R. de Paolantonio
Corporate headquarters
Raleigh, North Carolina

Forecasts